Avoiding the Premature Introduction of Psychedelic Medicines in Alzheimer’s Disease and Related Disorders

Taylor and Francis Group, AJOB Neuroscience, 2(14), p. 129-131, 2023

Journal article published in 2023 by Adrian Carter

Distributing this paper is prohibited by the publisher

Full text: Unavailable

Preprint: archiving forbidden

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by